1. Home
  2. VRAX vs ROMA Comparison

VRAX vs ROMA Comparison

Compare VRAX & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • ROMA
  • Stock Information
  • Founded
  • VRAX 2013
  • ROMA 2018
  • Country
  • VRAX United Kingdom
  • ROMA Hong Kong
  • Employees
  • VRAX N/A
  • ROMA N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ROMA Savings Institutions
  • Sector
  • VRAX Health Care
  • ROMA Finance
  • Exchange
  • VRAX Nasdaq
  • ROMA Nasdaq
  • Market Cap
  • VRAX 7.8M
  • ROMA 8.4M
  • IPO Year
  • VRAX 2022
  • ROMA 2024
  • Fundamental
  • Price
  • VRAX $2.37
  • ROMA $0.79
  • Analyst Decision
  • VRAX
  • ROMA
  • Analyst Count
  • VRAX 0
  • ROMA 0
  • Target Price
  • VRAX N/A
  • ROMA N/A
  • AVG Volume (30 Days)
  • VRAX 198.4K
  • ROMA 61.5K
  • Earning Date
  • VRAX 02-05-2025
  • ROMA 12-31-2024
  • Dividend Yield
  • VRAX N/A
  • ROMA N/A
  • EPS Growth
  • VRAX N/A
  • ROMA N/A
  • EPS
  • VRAX N/A
  • ROMA N/A
  • Revenue
  • VRAX $84,872.00
  • ROMA $1,265,509.00
  • Revenue This Year
  • VRAX $5,169.18
  • ROMA N/A
  • Revenue Next Year
  • VRAX $66.97
  • ROMA N/A
  • P/E Ratio
  • VRAX N/A
  • ROMA N/A
  • Revenue Growth
  • VRAX 7.03
  • ROMA N/A
  • 52 Week Low
  • VRAX $0.60
  • ROMA $0.40
  • 52 Week High
  • VRAX $9.00
  • ROMA $11.80
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 64.60
  • ROMA 47.29
  • Support Level
  • VRAX $1.51
  • ROMA $0.76
  • Resistance Level
  • VRAX $1.98
  • ROMA $0.87
  • Average True Range (ATR)
  • VRAX 0.18
  • ROMA 0.09
  • MACD
  • VRAX 0.03
  • ROMA 0.01
  • Stochastic Oscillator
  • VRAX 98.85
  • ROMA 49.77

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

Share on Social Networks: